• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    N

    Newport Hospital,Lifespan

    EST. 1873
    114论文总数
    1,386引用总数

    Newport Hospital is a private, nonprofit hospital located in Newport, Rhode Island. Together with The Miriam Hospital and Rhode Island Hospital, Newport Hospital is a member of the Lifespan health system.

    论文量&引用量时间轴

    机构学者

    论文(114)

    年份
    起
    –
    止
    排序
    1Open Letter: Six Steps Towards a National Plan of Protected Horticulture—a Call for Coordinated Action
    Sven Batke, David Barker, Darrell Jones, Jack Farmer, Noel O'Leary, Phil Morley, John Walgate, Lee Stiles, Luke Hibberd, Jason Perrott, Alfie Russell, Ralph Weir,

    The UK's growing reliance on imports and rising climate risks highlight the need to expand protected horticulture as a secure, low‐carbon source of fruit and vegetables. A resilient system will require coordinated national planning, fair cost‐sharing across government and industry, and strong collaboration with growers. With a joined‐up strategy, modern greenhouses can greatly strengthen the UK's long‐term food security.

    2026Plants, People, Planet(2026)
    引用
    AI阅读
    加入学术空间
    2Blood Culture Use in Medical and Surgical Intensive Care Units and Wards
    Valeria Fabre,Yea-Jen Hsu,Karen C. Carroll,Alejandra B. Salinas,Avinash Gadala, Chris Bower,Sarah Boyd,Kathleen O. Degnan, Pragya Dhaubhadel,Daniel J. Diekema,Marci Drees,Baevin Feeser,

    ImportanceBlood culture (BC) use benchmarks in US hospitals have not been defined.ObjectiveTo characterize BC use in adult intensive care units (ICUs) and wards in US hospitals.Design, Setting, and ParticipantsA retrospective cross-sectional study of BC use in adult medical ICUs, medical-surgical ICUs, medical wards, and medical-surgical wards from acute care hospitals from the 4 US geographic regions was conducted. Critical access hospitals, less than 6 months of BC data, and non-US hospitals were excluded. The study included BC use data from September 1, 2019, to August 31, 2021. Data were analyzed from February 23 to July 14, 2024.Main Outcomes and MeasuresThe primary outcome was BC use per 1000 patient-days. Adjusted means with 95% CIs were calculated using mixed-effects negative binomial regression models adjusted for unit type, hospital bed size, geographic region, seasonality, and state COVID-19 case load, with random intercepts accounting for clustering at unit and hospital levels. Secondary outcomes included blood culture positivity, single BCs, BC contamination, and minimum threshold for BC use where blood culture positivity would be optimized.ResultsA total of 362 327 blood cultures were analyzed from 27 medical ICUs, 35 medical-surgical ICUs, 121 medical wards, and 109 medical-surgical wards from 48 hospitals in 19 states and the District of Columbia. The adjusted mean BC use per 1000 patient-days was 273.1 (95% CI, 270.2-275.9) for medical ICUs, 146.0 (95% CI, 144.5-147.5) for medical-surgical ICUs, 80.3 (95% CI, 79.8-80.7) for medical wards, and 65.1 for medical-surgical wards. Blood culture use was significantly higher across all 4 unit types in hospitals with more than 500 beds compared with 500 or less beds and in the West-Midwest compared with other regions. Single blood culture and positive blood culture rates were below 10% across all 4 unit types. Of the 292 units, 97% had a mean BC contamination rate within 3% of the recommended threshold, and 51% were within 1%. The minimum BC use thresholds (ie, BC use below this number may represent undertesting) were 120 BCs per 1000 patient-days for medical ICUs, 80 BCs per 1000 patient-days for medical-surgical ICUs, and 30 BCs per 1000 patient-days for medical-surgical wards.Conclusions and RelevanceThe findings of this study suggest that blood culture positivity may help determine appropriate BC use for individual unit types.

    2025JAMA NETWORK OPEN(2025)引用:11
    引用
    AI阅读
    加入学术空间
    3Individualized Interactomes Derived from Pulmonary Endothelial Transcriptomics Collected at Point-of-Care Personalize Therapeutic Repositioning in Pulmonary Arterial Hypertension
    H. Wathieu, K. Cox-Flaherty, R. Wang,N. Singh,G. L. Baird, R. Sanders,M. Pereira,C. J. Mullin,J. R. Klinger, A. Ragavendron,E. O. Harrington,B. A. Maron,
    2024AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE(2024)
    引用
    AI阅读
    加入学术空间
    4Clinical Characteristics and Cycle Thresholds among Discordant and True Positive Test Results for Clostridiodes Difficile
    Michael Rossi, Emerald O’Rourke,Sara Geffert, Tao Hong, Andrea Collins, Tiffany L. Chargualaf,Francine Romo Touzard

    Background: The diagnosis of Clostridioides difficile infection (CDI) is challenging. Despite guideline-directed, multistep testing algorithms and diagnostic stewardship, the treatment of C. difficile colonization persists. The testing algorithm at our system utilizes an initial real-time PCR test (PCR) for Toxin B gene, which if positive, reflexes to an enzyme immunoassay (EIA) for detecting Toxins A and B. Discordant results (PCR +/EIA -) are suggestive of colonization, but the majority of patients with discordant results are treated for CDI. Correlation of C. difficile EIA B polymerase chain reaction (PCR) cycle thresholds (Ct) with the presence of free EIA and disease severity has been observed, but the ability to use Ct in the decision to treat patients with discordant results is unclear. Our study assesses if Ct values and other clinical characteristics favor treatment in select patients with discordant Methods: A retrospective chart review was performed of adult patients (≥ 18-year-old) with positive C. difficile PCR results that were admitted to our health system between June 01 and August 31, 2023. C. difficile PCR and Ct results were obtained by Cepheid GeneXpert and Toxin A and B EIA results were obtained by Meridian Bioscience Immunocard. Patients with discordant (PCR+/EIA) and true positive (PCR+/EIA+) results were compared. We assessed demographics, past medical history, clinical characteristics, severity of illness, PCR Ct values, treatment, and clinical outcomes including: 30-day all-cause mortality and re-admission, and 60-day CDI repeat testing and treatment. Results Of the 122 patients identified, 89 patients had discordant results and 43 had true positive Results: Severity of illness and other clinical and laboratory characteristics were similar between both groups. Mean Ct values were significantly lower for true positive results compared to discordant results, 24.28 vs 29.27, respectively (p26 (p=.08). Of the patients with discordant results, 73 completed treatment for CDI and no difference in clinical outcomes was observed compared to patients with discordant results that were not treated. Conclusion Ct values were lower among patients with true positive results compared to patients with discordant Conclusion: There were no statistically significant different rates of severe or fulminant CDI among patients with discordant results and Ct values < 26, although this finding may be limited by sample size and Ct may be helpful in deciding which discordant patients to treat.

    2024Antimicrobial Stewardship & Healthcare Epidemiology(2024)
    引用
    AI阅读
    加入学术空间
    5Impact of Mandatory Nucleic Acid Amplification Test (NAAT) Testing Approval on Hospital-Onset Clostridioides Difficile Infection (HO-CDI) Rates: A Diagnostic Stewardship Intervention
    Winston L McCormick,Gail Jackson,Sarah B Andrea,Valerie Whitehead,Tiffany L Chargualaf,Francine Touzard-Romo

    Misclassification of Clostridioides difficile colonization as hospital-onset C. difficile infection (HO-CDI) can lead to unnecessary treatment of patients and substantial financial penalties for hospitals. We successfully implemented mandatory C. difficile PCR testing approval as a strategy to optimize testing, which was associated with a significant decline in the monthly incidence of HO-CDI rates and lowering of our standardized infection ratio to 0.77 (from 1.03) 18 months after this intervention. Approval request served as an educational opportunity to promote mindful testing and accurate diagnosis of HO-CDI.

    2023Infection control and hospital epidemiology(2023)引用:2
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 114 篇论文

    合作机构(100)

    布朗大学合作论文 30
    罗德岛医院合作论文 9
    宾夕法尼亚大学合作论文 6
    罗德岛大学合作论文 5
    Lifespan合作论文 4
    Portsmouth Regional Hospital合作论文 3
    贝斯以色列女执事医疗中心合作论文 2
    哥伦比亚大学合作论文 2
    塔夫茨大学合作论文 2
    哈特福德医院合作论文 2

    机构统计